Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Naval Medical Center - San Diego
San Diego, California, United States
- Tunnell Cancer Center at Beebe Medical Center
Lewes, Delaware, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- Walter Reed Army Medical Center
Washington D.C., District of Columbia, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- University of Illinois Cancer Center
Chicago, Illinois, United States
- Fort Wayne Medical Oncology and Hematology
Fort Wayne, Indiana, United States
- Hematology Oncology Associates of the Quad Cities
Bettendorf, Iowa, United States
- Holden Comprehensive Cancer Center at University of Iowa
Iowa City, Iowa, United States
- Greenebaum Cancer Center at University of Maryland Medical Center
Baltimore, Maryland, United States
- Union Hospital Cancer Program at Union Hospital
Elkton, Maryland, United States
- Masonic Cancer Center at University of Minnesota
Minneapolis, Minnesota, United States
- Ellis Fischel Cancer Center at University of Missouri - Columbia
Columbia, Missouri, United States
- Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
- Cancer Institute of New Jersey at Cooper - Voorhees
Voorhees Township, New Jersey, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Monter Cancer Center of the North Shore-Lij Health System
Lake Success, New York, United States
- Ccop - North Shore University Hospital
Manhasset, New York, United States
- Don Monti Comprehensive Cancer Center at North Shore University Hospital
Manhasset, New York, United States
- Long Island Jewish Medical Center
New Hyde Park, New York, United States
- Stony Brook University Cancer Center
Stony Brook, New York, United States
- Presbyterian Cancer Center at Presbyterian Hospital
Charlotte, North Carolina, United States
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
- Wayne Memorial Hospital, Incorporated
Goldsboro, North Carolina, United States
- Wake Forest University Comprehensive Cancer Center
Winston-Salem, North Carolina, United States
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
Columbus, Ohio, United States
- Miriam Hospital
Providence, Rhode Island, United States
- Rhode Island Hospital Comprehensive Cancer Center
Providence, Rhode Island, United States
- Mountainview Medical
Berlin Corners, Vermont, United States
- Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont, United States
- Virginia Commonwealth University Massey Cancer Center
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2002
- Primary completion
- 30 Sept 2010
- Completion
- 31 Oct 2014
- Last update posted
- 21 Aug 2023
- Registered enrollment
- 105
- Registry id
- NCT00039130
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.